This is a historical report — it no longer reflects this drug's current status. Current status: Active Shortage. View this drug's full profile page →

Resolved

GLN-OLMESARTAN

GLENMARK PHARMACEUTICALS CANADA INC.

View this drug's full profile page →

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of GLN-OLMESARTAN in Canada?

Yes. GLN-OLMESARTAN 40MG has an active shortage reported to Health Canada (last updated October 29, 2026).

Why is GLN-OLMESARTAN not available?

The reason the manufacturer reported: Demand increase for the drug.

When will GLN-OLMESARTAN be available again?

The manufacturer's estimated resolution date is November 27, 2026. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Check with your pharmacist

StatusResolved

Same-ingredient products on fileNone found

Affected strength40MG

Report last updated2026-07-08

Checked by MedShort2026-11-13

What this means

Does this mean the shortage is completely over everywhere?

It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.

What should I do?

If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02469820

Strength

40MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

OLMESARTAN MEDOXOMIL

Tier

Unrated

Last Updated

2026-07-08

Reason for Shortage

Shortage of an inactive ingredient or component.

Source

View original report on healthproductshortages.ca ↗

Past Reports for This Drug

GLN-OLMESARTAN has 2 shortage/discontinuation reports on file — this is one of them.

2026-10-29

Active Shortage

Demand increase for the drug.

Other Products from GLENMARK PHARMACEUTICALS CANADA INC.

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ATOVAQUONE AND PROGUANIL HYDROCHLORIDE TABLETS

DIN 02466783

DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP

DIN 02462060

DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP 21

DIN 02421437

DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP 28

DIN 02421445

GLN-APREMILAST

30MG · DIN 02518910

GLN-ATOVAQUONE

750MG · DIN 02528495